Effect of Exercise on Post-Covid Symptoms

June 26, 2022 updated by: Seda Saka, Halic University

Effect of Strengthening and Relaxation Exercises on Musculoskeletal Pain, Anxiety, and Sleep Quality on Post-covid Symptoms

The study aimed to investigate the effects of strengthening and relaxation exercises on pain, anxiety, and sleep quality. 76 post-covid patients were randomized into experimental and control groups. Experimental group patients performed strengthening and relaxation exercises 3 times a week for 8 weeks. Control group patients did not perform any program. All participants were assessed with McGill Pain Scale short form (SFMPQ), short-form 36 (SF-36), Pittsburgh sleep quality index (PSQI) before and after the study.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

After COVID-19, musculoskeletal pain, anxiety, and sleep problems can continue. The study aimed to investigate the effects of strengthening and relaxation exercises on pain, anxiety, and sleep quality. The study was performed at Gaziosmanpaşa Education and Research Hospital with 76 post-covid patients that were randomized into experimental and control groups. Experimental group patients performed strengthening and relaxation exercises 3 times a week for 8 weeks. Control group patients did not perform any program. All participants were assessed with McGill Pain Scale short form (SFMPQ), short-form 36 (SF-36), and Pittsburgh sleep quality index (PSQI) before and after the study.

Study Type

Interventional

Enrollment (Actual)

76

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Turkey
      • Istanbul, Turkey
        • Gaziosmanpaşa Education and Research Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • to be between the ages of 18-65
  • to be diagnosed with Covid-19 in the last 3 months
  • to have a negative PCR test, or to have completed the 14-day isolation period

Exclusion Criteria:

  • have undergone surgery in the last 6 months
  • have severe mental retardation that would prevent communication

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Experimental Group
Performed strengthening and relaxation exercises 3 times a week for 8 weeks.
Other: Exercise
Strengthening and Relaxation Exercises
No Intervention: Control Group
There is no intervention

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
McGill Pain Scale short form (SFMPQ)
Time Frame: at the enrollment and after the study
It gives an information about the sensation, severity and effect of pain
at the enrollment and after the study
Short-Form 36 (SF-36)
Time Frame: at the enrollment and after the study
It asses general quality of life with 8 parameters
at the enrollment and after the study
Pittsburg Sleep Quality Index
Time Frame: at the enrollment and after the study
It asses sleep quality with 19 questions that each question scored between 0-3.
at the enrollment and after the study
Beck Anxiety Scale
Time Frame: at the enrollment and after the study
It asses anxiety levels with subjective and somatic factors
at the enrollment and after the study

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Halic University

Investigators

  • Study Director: Seda Saka, PhD, Halic University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 18, 2021

Primary Completion (Actual)

March 31, 2021

Study Completion (Actual)

July 8, 2021

Study Registration Dates

First Submitted

June 26, 2022

First Submitted That Met QC Criteria

June 26, 2022

First Posted (Actual)

June 28, 2022

Study Record Updates

Last Update Posted (Actual)

June 28, 2022

Last Update Submitted That Met QC Criteria

June 26, 2022

Last Verified

June 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • ssaka7

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on COVID-19

Clinical Trials on Exercise

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ukraine

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe